Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated Brentuximab Vedotin in combination chemotherapy for AIDS-related Hodgkin lymphoma in HIV-infected patients; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Hodgkin Lymphoma
• HIV Infection

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-03